Allurion Technologies, Inc. (ALUR)
1.09
-0.03
(-2.68%)
USD |
NYSE |
Feb 20, 16:00
1.08
-0.01
(-0.92%)
After-Hours: 20:00
Allurion Technologies EPS Diluted (Quarterly) : -1.531 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.017 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1888 |
| Boston Scientific Corp. | 0.4493 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.88M |
| Revenue (Quarterly) | 2.658M |
| Total Expenses (Quarterly) | 14.54M |
| Enterprise Value | 40.64M |
| Gross Profit Margin (Quarterly) | 44.43% |
| Profit Margin (Quarterly) | -447.1% |
| Earnings Yield | -531.5% |
| Normalized Earnings Yield | -843.11 |